Skip to main content
. 2022 Jul 16;41(10):1429–1439. doi: 10.1016/j.healun.2022.07.008

Table 2.

Multivariable Analysis on Antibody Response in LTR to a Three-Dose Regimen of COVID-19 mRNA Vaccine

Variable B SEB eB (adjusted odds ratio) 95% CI p-value
Intercept −8.758 2.599 - - -
History of treated allograft acute rejection 0.487 0.553 1.627 0.550-4.808 0.379
Time between lung transplantation and vaccination (per 1 year increment) 0.038 0.052 1.039 0.939-1.150 0.463
BNT162b2 vaccine (vs mRNA-1273) 1.906 0.688 6.724 1.745-25.916 0.006
Time between first and second doses (per 1 day increment) 0.123 0.064 1.131 0.998-1.283 0.055
Time between third dose and antibody testing
(per 1 day increment) −0.011 0.017 0.989 0.957-1.022 0.516
Prevaccine TTV viral load ≥6.2 log10 cp/mL 2.883 0.907 17.866 3.019-105.716 0.001
MMF/MPA 1.554 0.600 4.730 1.458-15.343 0.010
Tacrolimus 0.303 0.633 1.354 0.391-4.684 0.632
Steroids 0.769 1.001 2.157 0.303-15.335 0.442

B, regression coefficient; CI, confidence interval; MMF/MPA, mycophenolate mofetil/mycophenolic acid; SE, standard error; TTV, Torque teno virus.

Multivariable logistic regression analysis of the risk to be a non-responder was performed using SPSS 28.0 (IBM Statistics). Factors independently associated with poor vaccine response (p < 0.05) are in bold. Overall model statistics: χ2 = 42.407, p-value <0.001.